A Systematic Review and Network Meta‐Analysis of Regorafenib and TAS‐102 in Refractory Metastatic Colorectal Cancer

BACKGROUND. Regorafenib at different dosing strategies and TAS‐102 are treatment options for refractory metastatic colorectal cancer (mCRC). We aimed to evaluate the comparative effectiveness evidence supporting these different strategies. MATERIALS AND METHODS. We searched different databases for r...

詳細記述

保存先:
書誌詳細
出版年:Oncologist
主要な著者: Sonbol, Mohamad Bassam, Benkhadra, Raed, Wang, Zhen, Firwana, Belal, Walden, Daniel J., Mody, Kabir, Hubbard, Joleen M., Murad, M. Hassan, Ahn, Daniel H., Bekaii‐Saab, Tanios
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Inc. 2019
主題:
Gastrointestinal Cancer
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738316/
https://ncbi.nlm.nih.gov/pubmed/31164455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0189
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料